Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Inventory (2022 - 2024)

Historic Inventory for Whitehawk Therapeutics (WHWK) over the last 3 years, with Q4 2024 value amounting to $5.3 million.

  • Whitehawk Therapeutics' Inventory fell 1736.42% to $5.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.3 million, marking a year-over-year decrease of 1736.42%. This contributed to the annual value of $5.3 million for FY2024, which is 1736.42% down from last year.
  • Whitehawk Therapeutics' Inventory amounted to $5.3 million in Q4 2024, which was down 1736.42% from $5.5 million recorded in Q3 2024.
  • Over the past 5 years, Whitehawk Therapeutics' Inventory peaked at $6.4 million during Q4 2023, and registered a low of $202000.0 during Q1 2022.
  • Its 3-year average for Inventory is $3.6 million, with a median of $3.7 million in 2023.
  • Per our database at Business Quant, Whitehawk Therapeutics' Inventory surged by 178267.33% in 2023 and then tumbled by 1736.42% in 2024.
  • Over the past 3 years, Whitehawk Therapeutics' Inventory (Quarter) stood at $1.9 million in 2022, then surged by 245.35% to $6.4 million in 2023, then fell by 17.36% to $5.3 million in 2024.
  • Its Inventory was $5.3 million in Q4 2024, compared to $5.5 million in Q3 2024 and $6.1 million in Q2 2024.